chr11-58579409-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_053023.5(ZFP91):c.128G>A(p.Gly43Glu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000741 in 1,458,090 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_053023.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
ZFP91 | NM_053023.5 | c.128G>A | p.Gly43Glu | missense_variant | 1/11 | ENST00000316059.7 | |
ZFP91-CNTF | NR_024091.1 | n.296G>A | non_coding_transcript_exon_variant | 1/13 | |||
ZFP91 | NM_001197051.2 | c.128G>A | p.Gly43Glu | missense_variant | 1/11 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
ZFP91 | ENST00000316059.7 | c.128G>A | p.Gly43Glu | missense_variant | 1/11 | 1 | NM_053023.5 | P1 |
Frequencies
GnomAD3 genomes AF: 0.0000132 AC: 2AN: 151822Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000262 AC: 12AN: 45868Hom.: 0 AF XY: 0.000293 AC XY: 8AN XY: 27264
GnomAD4 exome AF: 0.0000811 AC: 106AN: 1306268Hom.: 1 Cov.: 31 AF XY: 0.000109 AC XY: 70AN XY: 642564
GnomAD4 genome AF: 0.0000132 AC: 2AN: 151822Hom.: 0 Cov.: 31 AF XY: 0.0000270 AC XY: 2AN XY: 74126
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Dec 12, 2023 | The c.128G>A (p.G43E) alteration is located in exon 1 (coding exon 1) of the ZFP91 gene. This alteration results from a G to A substitution at nucleotide position 128, causing the glycine (G) at amino acid position 43 to be replaced by a glutamic acid (E). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at